Testing the Combination of Anetumab Ravtansine With Either Nivolumab, Nivolumab and Ipilimumab, or Gemcitabine and Nivolumab in Advanced Pancreatic Cancer

NCT03816358 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

74

Enrollment

NIH

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Stage II Pancreatic Cancer AJCC v8
Stage III Pancreatic Cancer AJCC v8
Stage IV Pancreatic Cancer AJCC v8

Interventions

BIOLOGICAL: Anetumab Ravtansine
PROCEDURE: Biopsy Procedure
PROCEDURE: Biospecimen Collection
DRUG: Gemcitabine Hydrochloride
BIOLOGICAL: Ipilimumab
BIOLOGICAL: Nivolumab

Sponsor

National Cancer Institute (NCI)